Blood Group Typing Market Size, Share | Industry Trends

The blood group typing market is projected to reach USD 3.12 billion by 2021

(firmenpresse) - The blood group typing market is projected to reach $3.12 billion by 2021 from $1.95 billion in 2016, at a CAGR of 9.8%.
Growth in the blood group typing market is primarily attributed to the increasing demand for blood and blood products, growing number of road accidents and trauma cases that necessitate blood transfusion, need for blood grouping during prenatal testing, and increasing usage of blood group typing in forensic sciences. Stringent regulatory standards for blood transfusion are also expected to fuel the growth of the blood group typing market during the forecast period.

The blood group typing market is segmented based on product and service, technique, test type, end user, and region. Apart from comprehensive geographic & devices analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by players to maintain and increase their shares in the market.

Browse 68 market data tables and 69 figures spread through 146 pages and in-depth TOC on "Blood Group Typing Market.

Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=72074095

North America accounted for the largest share of the market in 2016. However, in the coming five years, growth in the market is expected to be centered on Asia. The increasing prevalence and incidence rate of chronic disorders in Asia provides growth opportunities for players in the market. Key players are focusing on strategies such as product launches and acquisitions to strengthen their foothold in the market.

The report provides insights on the following pointers:
•Market Penetration: Comprehensive information on the product portfolios of the top players in the blood group typing market.
•Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the blood group typing market.


•Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the blood group typing market.
•Market Development: Comprehensive information about emerging markets. This report analyzes the market for blood group typing products across geographies.
•Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the blood group typing market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=72074095

Based on technique, the market is segmented into PCR-based and microarray techniques, assay-based techniques, massively parallel sequencing, and other techniques. The PCR-based and microarray techniques segment is expected to grow at the highest CAGR during the forecast period. The large share and high growth of this segment can be attributed to the rising prevalence of chronic diseases and increasing R&D activities focused on understanding the molecular basis of blood and antibody-antigen interactions.
Based on the end user, the market is segmented into hospitals, blood banks, clinical laboratories, and other end users. The hospitals end-user segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the increasing awareness on blood donations and their importance, rising number of blood donations, and growing requirement of blood in surgical treatments.
Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
PresseKontakt / Agentur:
Bereitgestellt von Benutzer: dheerajshaha67
Datum: 24.05.2019 - 10:55 Uhr
Sprache: Deutsch
News-ID 1723640
Anzahl Zeichen: 3792

Kontakt-Informationen:
Ansprechpartner: Dheeraj Shaha
Stadt:

Northbrook

Telefon: 18886006441

Kategorie:

Gesundheitswesen - Medizin

Meldungsart: Finanzinformation
Versandart: Veröffentlichung
Freigabedatum: 24.05.2019

Diese Pressemitteilung wurde bisher 382 mal aufgerufen.

Microplate Systems Market | Increasing R&D Expenditure in the Pharmaceutical Industry ...
The growth of this market is mainly driven by factors such as the increasing R&D expenditure in the pharmaceutical industry, increasing focus on miniaturization, technological advancements, and growing prevalence of diseases. The report "Microplate Systems Market by Product (Microplate R

3D Cell Culture Market : Regenerative Medicine to Offer Global Growth In Coming Years ...
A 3D cell culture is an artificially created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Factors such as rising focus on developing alternative methods for animal testing, funding initiatives from government and private

Immuno Oncology Assays : Research Application Transforming the Industrial Business ...
What the Immuno Oncology Assays Market looks like? Growth in Immuno Oncology Assays Market is largely driven by factors such as the increasing adoption of targeted therapy over traditional therapy and the increasing demand for mAbs. According to the new market research report "Immuno Onco

Weitere Mitteilungen von MnM

MS Welt Tag 2019 ...
Am 30. Mai 2019 "dem Welt-Multiple-Sklerose-Tag" geht es darum, die Menschen auf die Betroffenen von Multiple Sklerose sowie deren Bedürfnisse aufmerksam zu machen. Dieser Tag wurde im Jahre 2009 von der Multiple Sklerose International Federation initiiert. Der Name Multiple Sklerose &

Katheterversorgung aus erster Hand ...
Neben Blasenentleerungsstörungen finden Katheter auch bei Erleichterung der postoperativen Pflege oder zur Überwachung der Urinproduktion schwer kranker Patienten Anwendung. Der Blasenkatheter ist ein Röhrchen, das Harn aus dem Körper ableitet, wenn die Blase des Betroffenen diese Funktion nicht

SKANDAL - Wie unheilbar kranke Menschen sich selbst geheilt haben ...
Tante Erna fühlte sich eigentlich gar nicht so krank als sie zu einer routinemäßigen Untersuchung im Krankenhaus war. Die Diagnose der Ärzte war allerdings eindeutig. Sie hatte Krebs im Endstadium und nur noch wenige Monate zu leben und sollte schon einmal die Erbthemen und ähnliches regeln. Ei

Fluorchinolone: Risikoreiche Antibiotika trotz bekannter Nebenwirkungen zu häufig verordnet ...
Etwa fünf Prozent der GKV-Versicherten haben 2018 ein Fluorchinolon-Antibiotikum verordnet bekommen. Damit gehören sie in Deutschland zu den häufig verordneten Antibiotika, obwohl sie ein erhöhtes Risiko für schwerwiegende Nebenwirkungen haben und zu den Reserve-Antibiotika zählen. Das Wis